Abstract
Parvovirus B19-infected hydrops fetalis was treated using gammaglobulin injection into the peritoneal cavity (GIFPeC) with B19-IgG-rich immunoglobulin. Fetal anemia and hydrops resolved, and B19-DNA in fetal ascites decreased despite no change in maternal B19-IgG or B19-DNA. Gammaglobulin injection into the peritoneal cavity is thus useful for treating hydrops fetalis while avoiding intrauterine blood-transfusion risks.
MeSH terms
-
Adult
-
Anemia / diagnosis
-
Anemia / etiology
-
Anemia / therapy
-
Antibodies, Viral / administration & dosage
-
Antibodies, Viral / therapeutic use
-
Erythema Infectiosum / complications
-
Erythema Infectiosum / congenital*
-
Erythema Infectiosum / diagnosis
-
Erythema Infectiosum / therapy*
-
Female
-
Fetal Diseases / diagnosis
-
Fetal Diseases / therapy*
-
Humans
-
Hydrops Fetalis / diagnosis
-
Hydrops Fetalis / etiology
-
Hydrops Fetalis / therapy
-
Immunoglobulin G / administration & dosage
-
Immunoglobulin G / therapeutic use
-
Infant, Newborn
-
Injections, Intraperitoneal
-
Male
-
Parvovirus B19, Human* / immunology
-
Parvovirus B19, Human* / pathogenicity
-
Pregnancy
-
Pregnancy Complications, Infectious / diagnosis
-
Prenatal Diagnosis
-
gamma-Globulins / administration & dosage
-
gamma-Globulins / therapeutic use*
Substances
-
Antibodies, Viral
-
Immunoglobulin G
-
gamma-Globulins